In a groundbreaking medical achievement, Nethradhama Super Speciality Eye Hospital has become the first in Asia to perform an intraocular lens (IOL) implantation using lenses designed with artificial intelligence. The pioneering surgery was performed by renowned ophthalmic surgeon Professor Dr. Sri Ganesh, Chairman & Managing Director of Nethradhama and Founder Trustee of Shraddha Eye Care Trust.

The hospital used the advanced Rayner RayOne Galaxy and Galaxy Toric IOLs — AI-optimized lenses that promise to transform cataract and refractive surgeries by offering unparalleled visual clarity across all distances, even in challenging low-light conditions.

Highlighting the importance of this milestone, Dr. Sri Ganesh said, “Our goal is always to provide the best solutions for our patients, and this innovation allows us to offer superior vision outcomes with minimal side effects. By leveraging AI-driven technology in intraocular lens design, we can achieve greater precision, enhanced customization, and improved patient satisfaction.”

The newly introduced lenses address long-standing challenges associated with conventional IOLs, particularly the balance between clear vision and night vision clarity. According to Dr. Ganesh, “This new lens overcomes these hurdles by using AI to optimize light distribution, offering patients exceptional visual experiences. Its non-diffractive, AI-optimized spiral design ensures seamless clarity at all distances, reduces halos and glare, and enhances contrast sensitivity in low-light environments.”

The toric variant of the lens is particularly beneficial for patients with astigmatism, providing superior rotational stability for precise vision correction. Designed for those seeking reduced dependence — or complete independence — from spectacles, these lenses are ideal for individuals who desire excellent day and night vision for activities like driving.

Dr. Ganesh shared that the initial post-operative results have been overwhelmingly positive, with patients reporting excellent clarity within the first 24 hours of the surgery. However, long-term follow-ups are planned to assess real-world performance, particularly during night driving and in dimly lit settings.

Globally recognized for his expertise in advanced eye surgeries, Dr. Sri Ganesh has an impressive record of over 100,000 Phaco surgeries and 50,000 refractive surgeries. He also serves on advisory boards for global vision technology leaders such as Carl Zeiss Meditec, Germany, and J&J Vision, USA. His contributions to ophthalmic innovation include multiple patents that continue to advance the field.

Nethradhama Super Speciality Eye Hospital ensures patients are well-informed before undergoing surgery by offering in-depth counseling and visual simulation sessions. These sessions enable patients to preview expected outcomes and better understand the benefits of AI-designed IOLs.

“With AI-driven advancements like these, we are witnessing a paradigm shift in ophthalmology,” Dr. Ganesh emphasized. “Our mission at Nethradhama Super Speciality Eye Hospital is to continually push the boundaries of innovation to provide our patients with the best possible visual outcomes. We are thrilled to bring this revolutionary technology to Asia and look forward to its impact on the future of vision correction.”

Under Dr. Sri Ganesh’s leadership, Nethradhama has established itself as a leader in innovation, research, and compassionate patient care, making significant contributions to global eye health.